MCRPC - PDFSEARCH.IO - Document Search Engine

MCRPC
Results: 35

#	Item
1	Intranet “Internal News” Posting & Leading Edge article, authored by Kathy, Dede or Rob Add to Reading List Source URL: www.cmsastellas.ca Language: English - Date: 2015-04-16 08:07:47 MCRPC Breast cancer Docetaxel Testosterone Cancer Nicholas J. Vogelzang Management of prostate cancer Medicine Prostate cancer Ribbon symbolism
2	BioMed Research International Special Issue on Optimal Sequencing and/or Combination of the New Drugs for mCRPC CALL FOR PAPERS Add to Reading List Source URL: downloads.hindawi.com Language: English - Date: 2015-03-15 04:33:13 Cancer treatments Abiraterone Docetaxel MCRPC Chemotherapy Cancer Metastasis William K. Oh Nicholas J. Vogelzang Medicine Oncology Prostate cancer
3	«ETTORE MAJORANA» FOUNDATION AND CENTRE FOR SCIENTIFIC CULTURE TO PAY A PERMANENT TRIBUTE TO GALILEO GALILEI, FOUNDER OF MODERN SCIENCE AND TO ENRICO FERMI, THE “ITALIAN NAVIGATOR”, FATHER OF THE WEAK FORCES INTERN Add to Reading List Source URL: www.ccsem.infn.it Language: English - Date: 2015-05-13 10:13:11 Metastasis Bladder cancer Urology MCRPC Oncology Erice Medicine Prostate cancer Oncologists
4	6.1 ABIRATERONE ACETATE, tablet, 250 mg, Zytiga®, Janssen-Cilag Pty Ltd Purpose of Application Authority required listing for abiraterone for treatment of metastatic castrate-resistant prostate cancer (mCRPC) after tre Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-11-12 19:13:31 Benzoates Carbamates Abiraterone Antiandrogens Pyridines Prostate cancer Docetaxel Cyclophosphamide Cabazitaxel Medicine Chemistry Organic chemistry
5	Daniel P. Petrylak, M.D. CURRICULUM VITAE Date of Revision: February 7, 2014 Name: Add to Reading List Source URL: yale-faculty.photobooks.com Language: English - Date: 2014-02-07 12:35:16 Management of prostate cancer Docetaxel Abiraterone Adjuvant therapy MCRPC Cancer Cyclophosphamide Radiation therapy William K. Oh Medicine Prostate cancer Oncologists
6	For UK consumer and medical media Embargoed until[removed]Thursday 11th July 2013 New treatment for the management of advanced prostate cancer after failure on first-line hormonal treatments and docetaxel chemotherapy, now Add to Reading List Source URL: www.astellas.com Language: English - Date: 2013-07-11 01:00:53 Cancer treatments Oncologists MDV3100 Docetaxel Prostate Institute of Cancer Research Management of cancer Hormone therapy MCRPC Medicine Oncology Prostate cancer
7	XTANDI™▼ (ENZALUTAMIDE) AUTHORISED IN THE EUROPEAN UNION (EU) FOR ADVANCED PROSTATE CANCER Enzalutamide authorised in European Union (EU) for the treatment of adult men with metastatic castration-resistant prostate c Add to Reading List Source URL: www.astellas.com Language: English - Date: 2013-06-23 21:02:09 Nitriles Organofluorides Prostate cancer MDV3100 Docetaxel MCRPC Institute of Cancer Research William K. Oh Management of prostate cancer Medicine Chemistry Organic chemistry
8	Microsoft Word - M0trial12 2 13final (3).docx Add to Reading List Source URL: www.astellas.com Language: English - Date: 2013-12-03 18:32:13 Prostate cancer Docetaxel MCRPC Antiandrogens Organofluorides Abiraterone William K. Oh Chemistry Medicine Organic chemistry
9	Issues Concerning Development of Products for Treatment of Non-Metastatic CastrationResistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting Add to Reading List Source URL: www.fda.gov Language: English Biochemical recurrence Androgen deprivation therapy MCRPC Metastasis Prostate Radiation therapy Management of prostate cancer William K. Oh Medicine Oncology Prostate cancer
10	ODAC Briefing for NM-CRPC Add to Reading List Source URL: www.fda.gov Language: English Prostate-specific antigen Bone metastasis MCRPC Management of prostate cancer William K. Oh Medicine Prostate cancer Metastasis

UPDATE